NCT02554747View on ClinicalTrials.gov

Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

November 30, 2018

Conditions
Diabetic Macular Oedema
Interventions
DEVICE

Navigated laser

Aflibercept, Navilas®

DEVICE

Conventional laser

Aflibercept, Pascal

Trial Locations (1)

5000

Research Unit of Ophthalmology, Clinical Institute, University of Southern Denmark, Department of Ophthalmology, Odense University Hospital., Odense

All Listed Sponsors
collaborator

Moorfields Eye Hospital NHS Foundation Trust

OTHER

lead

Odense University Hospital

OTHER

NCT02554747 - Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa | Biotech Hunter | Biotech Hunter